Evidence about medicines: our engagement with stakeholders

As part of our workstream on ‘Enhancing the use of scientific evidence to judge the potential benefits and harms of medicines’, the Academy engaged widely with a range of stakeholders.

This stakeholder engagement was part of our workstream on ‘Enhancing the use of scientific evidence to judge the potential benefits and harms of medicines’. Please visit our workstream policy project page for more information.

A programme of public and stakeholder engagement took place throughout the ‘Enhancing the use of scientific evidence to judge the potential benefits and harms of medicines’ project to ensure discussions were informed by the views of wider society. It included a programme of activities that engaged the public, patients and healthcare professionals in a deliberative dialogue to explore how individuals perceive and interpret medical scientific evidence.

The dialogue aimed to identify how evidence should be communicated, what the role of professionals are in this process, how individuals’ views of evidence are influenced by health beliefs, and what forms of evidence influence health decision-making.

 

 

Staff leads


2018 FORUM Annual Lecture - ‘Transforming healthcare through engineering and technology’

Book Now

Mentoring Masterclass, Cambridge

Book Now

Developing an effective mentoring programme

Book Now
View more
 
 
 
 
 
 
FB Twitter Instagram Youtube